서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 5 of 5

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2017-08	A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gemcitabine plus placebo Ueno, Makoto; Li, Chung Pin; Ikeda, Masafumi; Ishii, Hiroshi; Mizuno, Nobumasa; Yamaguchi, Taketo; Ioka, Tatsuya; Oh, Do Youn; Ichikawa, Wataru; Okusaka, Takuji; Matsuyama, Yutaka; Arai, Daichi; Chen, Li Tzong; Park, Young Suk; Furuse, Junji Cancer Chemotherapy and Pharmacology, Vol.80 No.2, pp.307-315	DOI
2023-04	Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial Bekaii-Saab, Tanios; Okusaka, Takuji; Goldstein, David; Oh, Do-Youn; Ueno, Makoto; Ioka, Tatsuya; Fang, Weijia; Anderson, Eric C.; Noel, Marcus S.; Reni, Michele; Choi, Hye Jin; Goldberg, Jonathan S.; Oh, Sang Cheul; Li, Chung-Pin; Tabernero, Josep; Li, Jian; Foos, Emma; Oh, Cindy; Van Cutsem, Eric EClinicalMedicine, Vol.58, p. 101897	DOI
2023-11	Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer Oh, Do-Youn; He, Aiwu Ruth; Qin, Shukui; Chen, Li-Tzong; Okusaka, Takuji; Vogel, Arndt; Kim, Jin Won; Suksombooncharoen, Thatthan; Lee, Myung Ah; Kitano, Masayuki; Burris, Howard; Bouattour, Mohamed; Tanasanvimon, Suebpong; McNamara, Mairead G.; Zaucha, Renata; Avallone, Antonio; Tan, Benjamin; Cundom, Juan; Lee, Choong-Kun; Takahashi, Hidenori; Ikeda, Masafumi; Chen, Jen-Shi; Wang, Julie; Makowsky, Mallory; Rokutanda, Nana; Żotkiewicz, Magdalena; Kurland, John F.; Cohen, Gordon; Valle, Juan W. Future oncology (London, England), Vol.19 No.34, pp.2277-2289	DOI
2024-05	Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial Burris, Howard A., III; Okusaka, Takuji; Vogel, Arndt; Lee, Myung Ah; Takahashi, Hidenori; Breder, Valeriy; Blanc, Jean-Frederic; Li, Junhe; Bachini, Melinda; Zotkiewicz, Magdalena; Abraham, Jayne; Patel, Nikunj; Wang, Julie; Ali, Muzammil; Rokutanda, Nana; Cohen, Gordon; Oh, Do-Youn LANCET ONCOLOGY, Vol.25 No.5, pp.626-635	DOI
2024-08	Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study Oh, Do-Youn; He, Aiwu Ruth; Bouattour, Mohamed; Okusaka, Takuji; Qin, Shukui; Chen, Li-Tzong; Kitano, Masayuki; Lee, Choong-kun; Kim, Jin Won; Chen, Ming-Huang; Suksombooncharoen, Thatthan; Ikeda, Masafumi; Lee, Myung Ah; Chen, Jen-Shi; Potemski, Piotr; Burris, Howard A; Ostwal, Vikas; Tanasanvimon, Suebpong; Morizane, Chigusa; Zaucha, Renata E; McNamara, Mairéad G; Avallone, Antonio; Cundom, Juan E; Breder, Valeriy; Tan, Benjamin; Shimizu, Satoshi; Tougeron, David; Evesque, Ludovic; Petrova, Mila; Zhen, David B; Gillmore, Roopinder; Gupta, Vineet Govinda; Dayyani, Farshid; Park, Joon Oh; Buchschacher, Gary L; Rey, Felipe; Kim, Hyosung; Wang, Julie; Morgan, Claire; Rokutanda, Nana; Żotkiewicz, Magdalena; Vogel, Arndt; Valle, Juan W The Lancet Gastroenterology & Hepatology, Vol.9 No.8, pp.694-704	DOI

1